Target intelligence / Profile preview

Host cell-surface attachment factors

Molecular classification
Proteoglycan, Glycoprotein, Glycolipid, Lectin, Cell surface receptor
01

Overview

Host cell-surface attachment factors are a heterogeneous group of molecules, including heparan sulfate proteoglycans (HSPGs), sialic acids, and other glycoconjugates, that mediate the initial, often low-affinity, adherence of pathogens to host cells (Maginnis, 2018 [4]). These factors act as a molecular velcro, concentrating viruses, bacteria, or parasites on the cell membrane to facilitate subsequent binding to specific, high-affinity entry receptors that trigger internalization (Cagno et al., 2019 [1]). For instance, many viruses like Herpes Simplex Virus (HSV) and SARS-CoV-2 utilize HSPGs for initial docking before engaging more specific protein receptors (Clausen et al., 2020 [2]). Because these attachment factors are frequently shared across multiple pathogen species, they are significant targets for the development of broad-spectrum entry inhibitors. Therapeutic strategies often involve the use of polyanionic compounds or lectins that mask these attachment sites or neutralize the pathogen's binding proteins, thereby preventing the establishment of infection at the earliest stage (O'Keefe et al., 2009 [3]). Beyond infection, these factors also play roles in cancer metastasis and inflammation by facilitating cell-to-cell and cell-to-matrix interactions.

Other names
Attachment factorsHost cell attachment receptorsAdhesion factorsPathogen attachment factorsLow-affinity attachment receptors
02

Mechanism of action

Drugs targeting host cell-surface attachment factors typically function as competitive inhibitors or molecular decoys that mimic the structure of the host factor, thereby binding to the pathogen's surface proteins and preventing their interaction with the actual cell surface (Maginnis, 2018 [4]; Cagno et al., 2019 [1]).

03

Biological functions

Cell adhesionPathogen recognitionCell-cell interactionExtracellular matrix organizationSignal transduction
04

Disease associations

InfectionInflammationCancer metastasis
05

Safety considerations

Systemic anticoagulation (for heparin-mimetics)Interference with growth factor signaling (e.g., FGF-2/HSPG interaction)Disruption of physiological cell-matrix adhesionOff-target binding to endogenous proteinsMucosal irritation
06

Interacting drugs

Heparin

6 more in the full profile.

07

Biomarkers

Heparan sulfate expression levelsSialic acid linkage patterns (alpha 2-3 vs alpha 2-6)Glycan-binding protein (GBP) profilesViral load

Beyond the preview

Go deeper on Host cell-surface attachment factors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cell-surface attachment factors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call